↓ Skip to main content

Xpert MTB/XDR for detection of pulmonary tuberculosis and resistance to isoniazid, fluoroquinolones, ethionamide, and amikacin

Overview of attention for article published in Cochrane database of systematic reviews, May 2022
Altmetric Badge

About this Attention Score

  • In the top 25% of all research outputs scored by Altmetric
  • High Attention Score compared to outputs of the same age (90th percentile)
  • Good Attention Score compared to outputs of the same age and source (68th percentile)

Mentioned by

blogs
1 blog
twitter
21 tweeters

Citations

dimensions_citation
7 Dimensions

Readers on

mendeley
45 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
Xpert MTB/XDR for detection of pulmonary tuberculosis and resistance to isoniazid, fluoroquinolones, ethionamide, and amikacin
Published in
Cochrane database of systematic reviews, May 2022
DOI 10.1002/14651858.cd014841.pub2
Pubmed ID
Authors

Samantha Pillay, Karen R Steingart, Geraint R Davies, Marty Chaplin, Margaretha De Vos, Samuel G Schumacher, Rob Warren, Grant Theron

Twitter Demographics

The data shown below were collected from the profiles of 21 tweeters who shared this research output. Click here to find out more about how the information was compiled.

Mendeley readers

The data shown below were compiled from readership statistics for 45 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Unknown 45 100%

Demographic breakdown

Readers by professional status Count As %
Student > Master 12 27%
Researcher 8 18%
Student > Postgraduate 4 9%
Student > Bachelor 3 7%
Unspecified 2 4%
Other 6 13%
Unknown 10 22%
Readers by discipline Count As %
Medicine and Dentistry 13 29%
Unspecified 7 16%
Biochemistry, Genetics and Molecular Biology 2 4%
Immunology and Microbiology 2 4%
Pharmacology, Toxicology and Pharmaceutical Science 2 4%
Other 6 13%
Unknown 13 29%

Attention Score in Context

This research output has an Altmetric Attention Score of 20. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 20 June 2022.
All research outputs
#1,546,308
of 22,053,897 outputs
Outputs from Cochrane database of systematic reviews
#3,611
of 12,174 outputs
Outputs of similar age
#32,335
of 339,729 outputs
Outputs of similar age from Cochrane database of systematic reviews
#7
of 19 outputs
Altmetric has tracked 22,053,897 research outputs across all sources so far. Compared to these this one has done particularly well and is in the 92nd percentile: it's in the top 10% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 12,174 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 29.9. This one has gotten more attention than average, scoring higher than 70% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 339,729 tracked outputs that were published within six weeks on either side of this one in any source. This one has done particularly well, scoring higher than 90% of its contemporaries.
We're also able to compare this research output to 19 others from the same source and published within six weeks on either side of this one. This one has gotten more attention than average, scoring higher than 68% of its contemporaries.